Last Update

This profile was last updated on 10/29/2017 and contains contributions from the  ZoomInfo Community.

is this you? Claim your profile.

Wrong Jon Anderson?

Jon C. Anderson

President, Chief Executive Officer

TKL Research , Inc.

HQ Phone:  (201) 587-0500

Direct Phone: (201) ***-**** ext. ****direct phone

Email: j***@***.com

Get Zoominfo Grow
Community Edition

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    the Plugin
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check Your Inbox to
    Sign Up for ZoomInfo Community Edition

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

TKL Research , Inc.

One Promenade Blvd Suite 1101

Fair Lawn, New Jersey, 07401

United States

Company Description

TKL Research provides comprehensive clinical trial management services for Phase 1-4 clinical research studies, including an inpatient Phase 1 facility and outpatient specialized research clinics. TKL has broad capabilities that include a unique patient recrui...more

Find other employees at this company (387)

Web References(12 Total References)


Clinical Research Facility | Phase I | TKL Research Leadership

Jon C. Anderson, PhD
President, Chief Executive Officer At the helm of TKL Research since 1981, Jon Anderson has provided strong and continuous leadership made possible by his past management experience in three major corporations in the pharmaceutical and consumer health industries. Dr. Anderson's hands-on approach has led TKL on a course of steady growth and success during his tenure. Graduating with a degree in Pharmacy from the Massachusetts College of Pharmacy and Health Sciences, Dr. Anderson continued his education with a MS and PhD in medicinal chemistry. He also maintains membership in several professional associations and is a past honoree and supporter of the American foundation for Pharmaceutical Education.


Clinical Research Organization | CRO | TKL Research Leadership

Jon C. Anderson, PhD
President, Chief Executive Officer Dr. Anderson has provided TKL Research with strong and continuous leadership since 1981. Before joining TKL, he served in numerous management positions in research and development for the pharmaceutical and consumer health industries. Dr. Anderson is a member of the Board of Trustees at the Massachusetts College of Pharmacy and Health Sciences in Boston, Massachusetts. His numerous professional affiliations include the American Academy of Dermatology, the American Association of Pharmaceutical Scientists and the American Society for Clinical Pharmacology and Therapeutics.


http://www.tklresearch.com/about-us/news-events-press-releases/

CW Weekly sat down with Jon Anderson, President & CEO of TKL Research, Inc. to talk about lessons learned as a mid-sized CRO during growth and development phases.


http://www.tklresearch.com/tkl-research-opens-new-primary-research-clinic.htm

"The Fair Lawn research facility will enable us to meet the increased demand for our services in the diseased-state populations for Phase I clinical trials in which we have strong patient recruitment expertise, " said TKL Research President and CEO Jon C. Anderson, Ph.D.
"This development offered an ideal opportunity for TKL", Anderson said.


http://www.scorrmarketing.com/news/tkl-research-is-building-new-clinical-research-facility-in-fair-lawn-n-j/

"The Fair Lawn research facility will enable us to meet the increased demand for our services in the diseased-state populations for Phase 1 clinical trials in which we have strong patient recruitment expertise," said TKL Research President and CEO Jon C. Anderson, Ph.D.
The new facility also complements the company's Clinical Trials Division, based in Rochelle Park, N.J., which provides a full-service capability in the clinical trial management of international, multicenter Phase 2-4 studies. Founded more than 60 years ago, TKL Research moved its CRO operations to Rochelle Park, N.J., in 2006, and expanded its European capabilities with clinical operations in Münster, Germany, in 2010. "These moves, as well as the construction of our new facility in Fair Lawn, will help us continue to deliver exceptional services to our clients that give them a competitive edge and accelerated enrollment," Anderson said.


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory